title: Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: relation to morphology, cell proliferation and expression of breast cancer-related genes.
abstract: Investigation of early breast carcinogenesis is limited by the difficulty in obtaining cell cultures or adequate fresh frozen material and by the fact that available data from in situ techniques are interpreted in terms of various classification systems. Our studies in a series of pure ductal carcinomas in situ (DCIS) were conducted in accordance with the recommendations of the international Consensus Conference (Hum. Pathol., 28, 122-125, 1997) relative to processing, determination of lesion extent, and histological stratification primarily on nuclear grade (NG). A multifactorial study performed in 15 low- and 16 high-NG DCIS (68% detected by mammography) included the following: (1) morphological analysis of NG, necrosis, and architectural pattern; (2) detection of numerical genomic abnormalities at ERBB2, MYC, CCND1, Xq1.2 and 20q13 loci by fluorescence in situ hybridization on interphase nuclei; and (3) immunohistochemical determination of cell proliferation, p53 accumulation, hormonal receptors and bcl-2 expression on serial sections of formalin-fixed, paraffin-embedded specimens. High NG, comedo/solid pattern and necrosis were significantly associated with amplification at one or more loci, the number of amplified loci, amplification at the ERBB2 locus, absence of bcl-2 and hormonal receptor expression and high cell proliferation (p < 0.05). High NG and comedo/solid pattern were significantly associated with MYC amplification and p53 accumulation, and necrosis with CCND1 amplification (the only gene amplification detected in low NG DCIS). These data provide additional information on the early steps of breast carcinogenesis, in accordance with currently recognized criteria of histological classification.
authors.affiliation: Nantes University Hospital, Nantes, France. mfiche@chu-nantes.fr
authors.forename: M
authors.initials: M
authors.lastname: Fiche
authors.forename: H
authors.initials: H
authors.lastname: Avet-Loiseau
authors.forename: C M
authors.initials: CM
authors.lastname: Maugard
authors.forename: C
authors.initials: C
authors.lastname: Sagan
authors.forename: M F
authors.initials: MF
authors.lastname: Heymann
authors.forename: M
authors.initials: M
authors.lastname: Leblanc
authors.forename: J M
authors.initials: JM
authors.lastname: Classe
authors.forename: P
authors.initials: P
authors.lastname: Fumoleau
authors.forename: F
authors.initials: F
authors.lastname: Dravet
authors.forename: M
authors.initials: M
authors.lastname: Mahé
authors.forename: B
authors.initials: B
authors.lastname: Dutrillaux
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D002278:Carcinoma in Situ / Q000235:genetics* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000235:genetics* / Q000473:pathology; D002455:Cell Division; D019938:Cyclin D1 / Q000235:genetics; D005260:Female; D005784:Gene Amplification; D018734:Genes, erbB-2; D016259:Genes, myc; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D008875:Middle Aged; D011519:Proto-Oncogenes
chemical_list: D019938:Cyclin D1